BCG Vaccine in Relation To COVID-19 Morbidity and Mortality |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.10, No. 6)Publication Date: 2020-11-06
Authors : Rauf Bhat; Sameh SM Soliman; Ahmed Fahmy; Mohamed I Husseiny;
Page : 578-587
Keywords : COVID-19 pandemic; BCG vaccination; Tuberculosis (TB); SARS-CoV-2; Infection Rate;
Abstract
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) significantly interrupts daily life activities leading to global social and economic disruption. The infected cases and deaths due to COVID-19 are continuously rising. The lower incidence of COVID-19-cases among countries with Bacillus-Calmette-Guérin (BCG) vaccination background raises the possibility that BCG vaccine could be a protective against COVID-19. Here, we studied the prevalence of COVID-19-cases in relation to population received BCG vaccination. The collected data were compared at two different time points for proper validation and execution of appropriate association. Our investigations showed a correlative association between BCG vaccination and the number of COVID-19-cases. The association obtained can be supported by the fact that BCG vaccination is associated with an increase in trained immunity.
Other Latest Articles
- Post-Intensive Care Syndrome |Biomedgrid
- The Lysosomal Storage Diseases: A Promising Axis for COVID-19 Future Therapies |Biomedgrid
- Major Contributions of the University of Wisconsin to Biomedical Science |Biomedgrid
- Immunomodulation with Thymalin in the COVID-19 Related Cytokine Storm: Case Reports |Biomedgrid
- Analysis of the long-term temperature trends in the Kofarnihon river basin in Tajikistan
Last modified: 2023-07-07 22:00:38